NOVEL NEGATIVE REGULATION OF STAT3 BYS-NITROSYLATION: A NEW THERAPEUTIC AVENUE FOR OVARIAN CANCER

$293,000FY2012Department of DefenseDOD

Henry Ford Health System, Detroit MI

Investigators